Stay updated on Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial page.

Latest updates to the Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial page
- Check6 days agoChange DetectedLocations sections were added with California, New Jersey, and New York sites, and the revision version updated to v3.3.3. The previous Location headings (California Locations, New Jersey Locations, New York Locations) were removed, and the HHS Vulnerability Disclosure link was deleted.SummaryDifference0.4%

- Check13 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing the previous Revision: v3.2.0.SummaryDifference0.1%

- Check42 days agoChange DetectedRemoved the government funding notice that previously appeared on the page. The core study information and eligibility criteria remain unchanged.SummaryDifference0.4%

- Check57 days agoChange DetectedStudy Details page appears unchanged in terms of title, conditions, eligibility, and locations. Any observed differences are limited to formatting or display.SummaryDifference0.4%

- Check85 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference3%

- Check92 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial page.